Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    16822992 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Conditions: Gastrointestinal Neoplasms;   Cancer of Gastrointestinal Tract;   Cancer of the Gastrointestinal Tract;   Gastrointestinal Cancer;   Neoplasms, Gastrointestinal
2 Recruiting Observational Study of Perioperative Chemotherapy in Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: epirubicin + cisplatin + capecitabine polychemotherapy
3 Active, not recruiting ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction
Conditions: Stomach Neoplasms;   Gastroesophageal Junction Neoplasms
Interventions: Drug: Epirubicin, Cisplatin, Capecitabine, Panitumumab;   Drug: Epirubicin, Cisplatin, Capecitabine
4 Active, not recruiting The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma
Condition: Gastric Cancer
Intervention: Drug: Capecitabine, Cisplatin and Docetaxel
5 Completed Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: cisplatin;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Procedure: conventional surgery

Indicates status has not been verified in more than two years